Nigeria

Resilience System


You are here

Liberia

Finishing Off Ebola

NEW YORK TIMES  OP-ED BY Ron Klain, the former White House Ebola response coordinaor                                    FEB. 20, 2015

...The world needs to do a better job of quickly detecting and responding to future outbreaks in unlikely places. The President’s Global Health Security Agenda, the government’s strategy to combat infection disease around the world, will help. But vulnerable countries, including those in Africa, need their own version of our Centers for Disease Control and Prevention, so that they are not so dependent on ours.

For the hardest task of front-line epidemic fighting, our planet is too reliant on courageous and talented — but underfunded, under-equipped and volunteer-dependent — nongovernmental organizations. The world needs a permanent standing force — or a ready reserve that can be quickly organized — of public health emergency responders who have the training, gear and resources to race into a region in the early phases of epidemic control. The United States military cannot do that job every time; future outbreaks might occur in countries where our troops will not be welcomed as they were in West Africa.

Problem, Solution, SitRep, or ?: 

Dr. David Nabarro - Ebola - UN General Assembly - Feb. 18, 2015

18 Feb 2015 - Statement by Dr. David Nabarro, Special Envoy of the Secretary-General on Ebola at the informal meeting of the plenary of the General Assembly on the latest developments concerning the Ebola epidemic.

http://webtv.un.org/watch/david-nabarro-on-ebola-informal-meeting-of-the-general-assembly-18-february-2015/4066125793001

CLICK HERE FOR ADDITIONAL RELATED VIDEOS AND SUPPORTING DOCUMENTATION

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Mapping the Zoonotic Niche of Ebola Virus Disease in Africa

submitted by Stephen Morse

elifesciences.org - September 8, 2014 - eLife 2014;3:e04395
DOI: http://dx.doi.org/10.7554/eLife.04395

Ebola virus disease (EVD) is a complex zoonosis that is highly virulent in humans. The largest recorded outbreak of EVD is ongoing in West Africa, outside of its previously reported and predicted niche. We assembled location data on all recorded zoonotic transmission to humans and Ebola virus infection in bats and primates (1976–2014). Using species distribution models, these occurrence data were paired with environmental covariates to predict a zoonotic transmission niche covering 22 countries across Central and West Africa. Vegetation, elevation, temperature, evapotranspiration, and suspected reservoir bat distributions define this relationship. At-risk areas are inhabited by 22 million people; however, the rarity of human outbreaks emphasises the very low probability of transmission to humans. Increasing population sizes and international connectivity by air since the first detection of EVD in 1976 suggest that the dynamics of human-to-human secondary transmission in contemporary outbreaks will be very different to those of the past.

Problem, Solution, SitRep, or ?: 

Ebola: the race to find a cure

 In October, scientists set out to do something unprecedented – conduct a drugs trial during an epidemic to find a treatment for a lethal disease. Could they make history and change the way we deal with outbreaks?

THE GUARDIAN  by Sarah Boseley                           Feb, 17, 2015

In depth description of efforts by a group of Oxford University scientists to run field trials of drugs for use against Ebola.

" ...The little band of scientists had flown to Guinea on 16 October to do something that had never been successfully done before – set up a trial of experimental drugs against an infectious disease in the middle of an epidemic. Because the Ebola virus does not exist at low levels in any population, unless you run a properly conducted trial while the storm is raging, you will never have drugs that are proven to be effective. The Oxford team’s trial would not only aim to find a drug that worked against Ebola but also to establish a blueprint for the way drug trials would be run during outbreaks in the future. This did not just apply to fighting Ebola: if the scientists were successful, their trial would develop protocols for testing drugs for any epidemic, be it Sars or flu...."

Read complete story.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

UN Mission for Ebola Emergency Response (UNMEER) External Situation Report

UN Mission for Ebola Emergency Response (UNMEER)                                                         Feb. 16, 2015

Conakry, Guinea --Statement issued by the heads of Guinea, Liberia and Sierra Leone upon approving an operational framework designed to reduce new Ebola infections to zero within 60 days.

The framework calls for infection prevention and control, social mobilization, community engagement, surveillance, cross border collaboration. 

The leaders also "advocated for a seamless and responsible exit by international partners dictated by the epidemiology and by the adequate transfer of capacity to national institutions."

The statement includes a list of developments and responses.

Read complete statement.

https://ebolaresponse.un.org/sites/default/files/150216-_unmeer_external_situation_report.pdf

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Doctors Who Treat Ebola Feel More Socially Isolated

LIVESCIENCE.COM   by Rachael Rettner                                                                         Feb. 13, 2015

Doctors who take care of very sick Ebola patients may feel socially isolated, but surprisingly, they may not feel more stressed than usual, a new study from Germany suggests.

Researchers surveyed 46 health care workers who treated Germany's first Ebola patient in August 2014, as well as 40 health care workers who worked in the same hospital but did not treat the Ebola patient.

The researchers who did the study hypothesized that the people who treated the Ebola patient would have more symptoms of psychological distress because they were working in a challenging environment that presented a risk that they could become infected with the deadly virus.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Ebola in west Africa: learning the lessons

THE LANCET  by  Anna  Petherick  Volume 385, No. 9968, p591–592, 14 February 2015
The (West Africa) region has presented unforeseen challenges, and the three worst affected countries have put in place different response strategies. Anna Petherick reviews some of the lessons learned so far.

The early history of the ongoing Ebola outbreak in west Africa is a salutary statement about the lack of infectious disease surveillance capacity in one of the world's poorest regions....

Opportunities to contain the virus were lost soon after, largely because of a lack of trust between local communities and the officials and medical professionals trying to nip the epidemic in the bud.

Read complete story

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960075-7/fulltext

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Ebola spending: will lack of a positive legacy turn dollars to dolour?

Millions were invested in west Africa to tackle the Ebola crisis, but some experts doubt there will be any lasting benefits for public health systems

THE GUARDIAN by 

LONDON -- While it is still too early to call time on the Ebola outbreak, a sense that the worst may have passed is tentatively taking root in west Africa, alongside an acute realisation of the need to ensure a positive long-term legacy for battered healthcare systems.

Problem, Solution, SitRep, or ?: 

Why Didn't Ebola Kill Me?

An ambulance transports the author to the Nebraska Medical Center in October. (Sait Serkan Gurbuz/Reuters)

THE ATLANTIC by Ashoka Mukpo                                                                          Feb. 12, 2015

Like the majority of patients taken to Western hospitals, I recovered from the disease—but health authorities are still struggling to figure out how to bring up the much-lower survival rate in West Africa.

...the 80-percent survival rate among patients who were evacuated to Western hospitals shattered the idea that an Ebola diagnosis spelled near-certain death. I know this all too well, as I’m one of those patients myself. In October, I contracted Ebola while covering the outbreak as a freelance journalist in Liberia. I was airlifted to a hospital in Nebraska, where aggressive treatment likely saved my life....
Read complete story.

http://www.theatlantic.com/health/archive/2015/02/why-didnt-ebola-kill-me/385335/

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Lack of Effect of Lamivudine on Ebola Virus Replication

CDC EID JOURNAL by  Lisa E. Hensley, Julie Dyall, Gene G. Olinger, and Peter B. Jahrlin (NIH)                     Feb. 12, 2015

The unprecedented number of Ebola virus disease (EVD) cases in western Africa has compelled the world to consider experimental and off-label therapeutics to mitigate the current outbreak. For clinicians, approved drugs are an attractive solution because of known safety profiles and availability.

Oral lamivudine (GlaxoSmithKline, Brentford, UK), a US Food and Drug Administration–approved anti-HIV drug, has been suggested as a possible antiviral agent against Ebola virus (EBOV). In September 2014, a Liberian physician, Dr. Gorbee Logan, reported positive results while treating EVD with lamivudine (1). Thirteen of 15 patients treated with lamivudine survived presumed EVD and were declared virus free. Clinical confirmation of EVD in these cases remains to be verified....

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Liberia
howdy folks